Domino's Pizza
DPZ
$333.23
+1.41%
Domino's Pizza Inc. is the world's largest pizza chain, operating over 22,100 stores across more than 90 markets with system sales exceeding $20 billion, and generates revenue primarily through a vertically integrated supply chain segment (roughly 60% of revenue from 25 manufacturing and distribution facilities serving US and Canadian stores), domestic company-owned and franchise operations (about 33%), and international franchise royalties (roughly 7%), with a business that is approximately 99% franchised. Its competitive identity rests on a capital-light, franchise-heavy model paired with an unusually asset-heavy dough and food-supply manufacturing arm, giving it both royalty-like economics and industrial operating leverage that few restaurant peers possess. The current investor narrative is dominated by a difficult 2026: a surprise CEO transition, slowing US same-store sales, and a lowered outlook drove shares to a 52-week low in late June, and while the Q3 beat on both earnings and revenue has stabilized sentiment, the stock remains down roughly 21% year-to-date and the debate centers on whether new leadership can reaccelerate US traffic and international unit growth. Additional overhangs include Berkshire's disclosed exit from the position under new CEO Greg Abel and a valuation that has compressed sharply from prior-year levels, leaving investors weighing a potential turnaround against persistent execution risk.…
DPZ
Domino's Pizza
$333.23
Related headlines
Investment Opinion: Should I buy DPZ Today?
Rating: Hold with a constructive lean. The core thesis is that Domino's is a high-quality, 99%-franchised, 40%-gross-margin business trading at a genuinely discounted 16.20x forward PE, but the ~47% earnings recovery embedded in the $26.24 consensus EPS is unproven under a new CEO, and the sell-side consensus of 2.2 (14 Buy / 15 Hold / 1 Sell) with an average target of $356.48 offers only 6.6% upside — not enough compensation for the execution risk until US same-store sales inflect.
The supporting evidence is real: trailing PE of 23.81x compresses to 16.20x forward, sitting in the bottom third of the 18.5x–39.4x historical band; Q3 2026 operating margin expanded to 20.39% from 19.46% and net margin to 12.84% from 12.15% even as revenue grew just 3.36%; trailing free cash flow of $635.7 million funded $73.6 million of buybacks and $66.1 million of dividends in the quarter; and the stock has rebounded 10.29% in the past month versus SPY's -4.99% (relative strength +15.28). Against that, the PEG of 4.60 shows the market is discounting the forward estimate, and the -21.40% YTD decline with -29.23 relative strength versus SPY confirms the de-rating has been idiosyncratic, not market-driven.
The biggest risks that could invalidate the thesis are a guidance cut to the $26.24 forward EPS (the low estimate is already $25.29), continued US traffic declines transmitting through the 60%-of-revenue supply-chain segment, and a further multiple de-rating toward the 18.5x historical floor. This Hold would upgrade to Buy if US same-store sales turn positive and the forward EPS estimate holds above $26, or if the price falls toward the $282 52-week low while fundamentals stabilize; it would downgrade to Sell if forward EPS is cut below $25 or the stock breaks decisively below $282. On balance the stock looks modestly undervalued relative to its own history but only fairly valued versus the near-term earnings reality — a value-with-a-catalyst-watch, not a clean bargain.
Sign up to view all
DPZ 12-Month Price Forecast
The forward-looking picture is a tug-of-war between a genuinely cheap 16.20x forward multiple and an earnings recovery the market is visibly discounting via a 4.60 PEG. The business quality is intact — 40% gross margins, expanding operating margins, and $635.7 million of trailing free cash flow — but 3.36% revenue growth and an unresolved CEO transition mean the recovery is a show-me story. Analyst sentiment is constructive but not conviction-driven: 15 of 27 rate Hold and the average target implies only 6.6% upside, while the wide $257–$425 range reflects real disagreement about the trajectory. I would upgrade to bullish if US same-store sales turn positive and the $26.24 forward EPS holds, and downgrade to bearish if forward EPS is cut below $25 or the stock breaks below the $282 52-week low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Domino's Pizza's 12-month outlook, with a consensus price target around $356.48 and implied upside of +7.0% versus the current price.
Average Target
$356.48
30 analysts
Implied Upside
+7.0%
vs. current price
Analyst Count
30
covering this stock
Price Range
$257 - $425
Analyst target range
Coverage is broad, with 27 analysts publishing ratings: 14 Buy, 15 Hold, and 1 Sell, yielding a consensus recommendation of "buy" but a recommendation mean of 2.2 that leans closer to neutral than the headline label implies. The average target price of $356.48 implies roughly 6.6% upside from the current $334.28, a modest expected return that is consistent with a stock where the sell-side sees value but lacks conviction on near-term catalysts. The distribution — more than half the coverage at Hold — signals that analysts are waiting for evidence of a US sales turnaround and clarity on the CEO transition before turning more constructive.
The target range of $257.00 to $425.00 is wide, spanning a 65% spread from low to high, which signals genuine disagreement about the trajectory rather than a consensus view. The high target of $425.00 (roughly 27% above the current price) likely assumes successful execution under new leadership, reaccelerating US same-store sales, international unit growth, and multiple expansion back toward the 25x–30x range; the low target of $257.00 (about 23% below current) prices in continued traffic declines, margin compression from commodity and labor costs, and a de-rating toward the low end of historical multiples. Recent institutional actions from the October 14, 2026 post-earnings cycle show a stable-to-cautious tone — BTIG, BofA, StoneX, and Mizuho maintained Buy/Outperform ratings while RBC, Baird, Citigroup, Morgan Stanley, Wells Fargo, and TD Cowen stayed at Hold/Neutral/Equal Weight, with no upgrades or downgrades — indicating that the Q3 beat was enough to prevent downgrades but not enough to shift the cautious majority.
Bulls vs Bears: DPZ Investment Factors
The bear case currently holds the stronger evidence base: revenue growth of just 3.36%, a surprise CEO transition, Berkshire's exit, and a -21.40% YTD decline with -29.23 relative strength against SPY are concrete, realized negatives, whereas the bull case rests largely on a forward EPS estimate the market is visibly discounting via a 4.60 PEG. That said, the bulls have real ammunition — expanding operating margins (20.39% vs. 19.46%), $635.7 million of trailing FCF, and a forward PE of 16.2x that sits in the bottom third of the 18.5x-39.4x historical band — which is why 14 of 27 analysts still rate Buy and the stock has rebounded 10.29% in the past month. The single most important tension is whether the implied ~47% earnings recovery to $26.24 per share materializes under new leadership; if it does, the stock is cheap on a 16.2x forward multiple, and if it does not, the current price is a value trap. Everything else — the dividend, the buybacks, the technical recovery off $282 — is secondary to that one question, which will be answered by US same-store sales trends over the next two to three quarters.
Bullish
- Forward PE of 16.2x is deeply discounted: The trailing PE of 23.81x collapses to a forward PE of 16.20x on analyst EPS of $26.24, a 32% compression that is far steeper than the sector's typical forward discount. For a 99%-franchised business with 40.18% gross margins and a 19.3% operating margin, that multiple prices in substantial execution fear rather than inferior business quality.
- Margins expanding despite sales slowdown: Q3 2026 operating margin rose to 20.39% from 19.46% a year earlier and net margin improved to 12.84% from 12.15%, with EPS of $4.61 up 13% from $4.08. Gross margin has held in a tight 39.7%-40.4% band for eight straight quarters, demonstrating pricing power and supply-chain cost control even as US traffic decelerates.
- Strong free cash flow funds aggressive capital returns: Trailing free cash flow of $635.7 million against just $21.8 million of quarterly capex generated $146.2 million of Q3 FCF, funding $73.6 million of buybacks and $66.1 million of dividends entirely from operations. The 1.65% dividend yield on a 39.4% payout ratio leaves ample room for continued repurchases that shrink the share count (34.1 million diluted in Q3 2025 to 33.1 million in Q3 2026).
- Momentum has inflected off the June capitulation: DPZ is up 10.29% over the past month versus SPY's -4.99%, a relative strength reading of +15.28, and the 6-month change of +3.34% beats SPY's -0.54%. The stock sits 32.7% of the way up its 52-week range after bottoming near $283, suggesting accumulation is underway following the Q3 beat.
Bearish
- US same-store sales deceleration is unresolved: Q3 revenue grew only 3.36% year-over-year to $1.186 billion, a far cry from the double-digit growth investors previously paid 28x-39x earnings for. Because 60% of revenue comes from the supply-chain segment levered to US store volumes, slowing domestic traffic transmits directly to the top line with no high-margin royalty offset.
- CEO transition and Berkshire exit create overhang: A surprise CEO change drove shares to a 52-week low of $282.00 in late June, and Berkshire's new CEO Greg Abel exited the Domino's position entirely, signaling a loss of a high-profile institutional anchor. Leadership uncertainty at the top of a turnaround story is precisely when investors demand a discount, not a premium.
- Negative equity and leverage constrain flexibility: Years of buybacks have pushed book equity below zero, producing an ROE of -15.42% and debt-to-equity of -1.34 that make P/B of -3.67 meaningless as a valuation anchor. Interest expense of $46.2 million and roughly 5.2x coverage are manageable today, but refinancing at higher rates would bite into the thin 12.2% net margin.
- PEG of 4.60 shows skepticism on the recovery: The market is being asked to believe earnings grow roughly 47% to $26.24 per share over the next twelve months, yet the PEG ratio of 4.60 implies investors doubt that trajectory. If estimates are cut, the apparent 16.2x forward cheapness proves illusory and the stock re-rates lower on the same multiple.
DPZ Technical Analysis
DPZ is in a recovery phase within a broader downtrend: the stock is down 16.73% over the trailing year and 21.40% year-to-date, but the current price of $334.28 sits at roughly 32.7% of its 52-week range of $282.00 to $442.35, meaning it has rebounded meaningfully off the June low yet remains far below the highs. That positioning — closer to the floor than the ceiling but well off the bottom — suggests the market has priced in a good deal of bad news without yet confirming a durable trend reversal, and the maximum drawdown of -35.44% underscores how violent the de-rating has been. The stock is not overextended at these levels, but it also lacks the momentum signature of a confirmed uptrend.
Short-term momentum has turned decisively positive and is diverging sharply from the longer-term trend: DPZ is up 10.29% over the past month versus a 4.99% decline for SPY, producing a relative strength reading of +15.28, while the 3-month change of -4.75% is essentially in line with SPY's -4.91% (relative strength +0.16). This one-month outperformance against a falling market is a classic mean-reversion signal off the June capitulation low near $283, reinforced by the 6-month change of +3.34% versus SPY's -0.54% (relative strength +3.88), suggesting accumulation is underway. The most recent session, however, saw a -2.15% pullback to $334.28 from $341.63 on volume of roughly 653,509 shares, a reminder that the rally off the lows has been choppy rather than linear.
Key technical levels are well defined: support sits at the 52-week low of $282.00, roughly 15.6% below the current price, while resistance lies at the 52-week high of $442.35, about 32.3% above — a wide band that reflects the stock's recent volatility. A breakout above the August highs near $367 would signal that the recovery has legs and likely open a path toward the $400s, whereas a breakdown below $282 would confirm the downtrend and target new lows. With a beta of 0.967, DPZ is slightly less volatile than the market on a trailing basis, but its realized drawdown of -35.44% versus SPY's far milder decline shows that idiosyncratic company risk — not market beta — has been the dominant driver of losses, which argues for position sizing based on event risk (earnings, CEO transition) rather than index correlation.
Beta
0.97
0.97x market volatility
Max Drawdown
-35.4%
Largest decline past year
52-Week Range
$282-$442
Price range past year
Annual Return
-17.5%
Cumulative gain past year
| Period | DPZ Return | S&P 500 |
|---|---|---|
| 1m | +12.5% | -2.7% |
| 3m | -3.8% | -2.5% |
| 6m | +10.2% | +2.4% |
| 1y | -17.5% | +10.8% |
| ytd | -21.6% | +11.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DPZ Fundamental Analysis
Revenue growth is modest but stable: Q3 2026 revenue of $1.186 billion grew 3.36% year-over-year from $1.147 billion in Q3 2025, extending a pattern of low-single-digit top-line expansion across the trailing four quarters ($1.151B in Q1, $1.194B in Q2, $1.186B in Q3, and $1.536B in the seasonally strong Q4 2025). Segment data shows the supply chain business at $746.2 million and domestic stores at $355.7 million dwarfing international franchise revenue of $83.7 million, meaning overall growth is levered to US store volumes and commodity pass-through rather than high-margin royalty streams — a structural drag when US same-store sales slow. The deceleration narrative that drove the stock to its 52-week low is visible in the gap between 3.4% revenue growth and the double-digit growth investors had grown accustomed to, and reaccelerating US traffic is the central pillar of any bull case.
Profitability remains solid and is actually improving: Q3 2026 net income of $152.2 million on a 12.84% net margin rose from $139.3 million and a 12.15% margin in Q3 2025, while gross margin held steady at 40.18% versus 40.09% a year earlier. Operating margin expanded to 20.39% from 19.46%, and EBITDA grew to $262.0 million (22.10% margin) from $244.6 million (21.33%), with EPS of $4.61 versus $4.08 — a 13% increase that comfortably beat consensus. The sequential trend is also constructive: net margin climbed from 12.15% in Q1 to 11.37% in Q2 to 12.84% in Q3, and gross margin has been remarkably stable in the 39.7%–40.4% band for eight straight quarters, which is consistent with the pricing power and supply-chain cost control typical of best-in-class franchisors.
Balance sheet optics are distorted by a deeply negative equity position — ROE of -15.42% and debt-to-equity of -1.34 reflect years of buybacks that have pushed book equity below zero, so P/B of -3.67 is not meaningful — but cash generation is robust: trailing free cash flow of $635.7 million, quarterly FCF of $146.2 million in Q3, and operating cash flow of $168.0 million against capex of just $21.8 million. The current ratio of 1.65 and cash balance of $468.4 million provide adequate liquidity, and the company returned capital aggressively in Q3 via $73.6 million of buybacks and $66.1 million of dividends, funded entirely from operations. Interest coverage of roughly 5.2x and interest expense of $46.2 million are manageable, but the leverage inherent in the negative-equity structure means refinancing costs and rate sensitivity remain a genuine risk factor.
Quarterly Revenue
$1.2B
2026-09
Revenue YoY Growth
+3.4%
YoY Comparison
Gross Margin
40.2%
Latest Quarter
Free Cash Flow
$635687000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DPZ Overvalued?
Because DPZ is solidly profitable — Q3 2026 net income of $152.2 million and trailing EPS of $4.61 — the PE ratio is the appropriate primary metric, and the trailing PE of 23.81x against a forward PE of 16.20x implies the market expects earnings to grow roughly 47% over the next twelve months, a gap that is unusually wide and reflects both depressed trailing comparisons and analyst expectations of $26.24 in forward EPS. That forward multiple of 16.2x is undemanding in absolute terms for a franchise business with 40% gross margins, and the PEG ratio of 4.60 suggests the market is skeptical that the growth implied by the forward estimate will actually materialize. The 1.65% dividend yield with a 39.4% payout ratio adds a modest income cushion.
Against its own sector, DPZ screens as a relative value: the PS ratio of 2.90x and EV/sales of 3.14x are low for a franchised restaurant platform, and the EV/EBITDA of 18.04x sits at the lower end of what quality QSR franchisors typically command. The trailing PE of 23.81x versus a forward PE of 16.20x represents a 32% compression, far steeper than the sector's typical forward-discount, which suggests the market is pricing in either a genuine earnings recovery or skepticism about the forward estimate. Given the 19.3% operating margin and 12.2% net margin — both above restaurant-industry norms — the current multiple looks more like a discount for execution risk than a reflection of inferior business quality.
Historically, DPZ's PE has ranged from roughly 18.5x to 39.4x over the past several years, and the current 23.81x trailing multiple sits in the lower third of that band — well below the 28.4x–32.7x levels seen in 2025 and the 39.4x peak in early 2022. The PS ratio of 2.90x is dramatically below the 9.3x–16.9x range recorded across 2024–2025, though that comparison is distorted by the recent market-cap data versus historical ratio snapshots. The takeaway is that the stock is near the bottom of its own valuation band, which historically has marked attractive entry points — but only if the earnings recovery implied by the forward PE materializes; if estimates are cut, the apparent cheapness could prove illusory.
PE
23.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~39x
vs. Industry Avg
27.2x
Industry PE ~27.2x*
EV/EBITDA
18.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the gap between the forward earnings estimate and delivered results. Analysts model $26.24 in forward EPS, roughly 47% above the trailing $4.61 quarterly run-rate annualized, yet Q3 revenue grew only 3.36% and the PEG ratio of 4.60 shows the market doubts that acceleration; any guidance cut would compress the multiple and the estimate simultaneously. The negative-equity capital structure (ROE -15.42%, debt-to-equity -1.34) means interest expense of $46.2 million and roughly 5.2x coverage are the only cushion against higher refinancing costs, and with 60% of revenue tied to the supply-chain segment, a US traffic slowdown transmits directly to sales with limited royalty insulation. Finally, the 12.2% net margin leaves little room for commodity or labor cost shocks, and the 99% franchise model means the company cannot directly fix store-level execution. Market and competitive risks are dominated by valuation compression and sentiment. The stock has already de-rated from 28.4x-32.7x in 2025 and a 39.4x peak in early 2022 to 23.81x trailing, and a further move toward the 18.5x low end of its historical band would imply roughly 22% downside on unchanged earnings. Beta of 0.967 offers little protection because the -35.44% max drawdown versus SPY's far milder decline proves idiosyncratic risk, not market correlation, has driven losses; the Berkshire exit under Greg Abel removes a stabilizing institutional holder and signals a shift in smart-money positioning. Competitive pressure from Burger King's $700 million turnaround at Restaurant Brands and aggressive value promotions across QSR, plus a consumer trading down amid persistent traffic declines, threaten the US same-store sales recovery the bull case requires. The worst-case scenario is a chain of events in which the new CEO's strategic review produces a lowered 2027 outlook, US same-store sales turn negative, and analysts cut the $26.24 forward EPS toward the $25.29 low estimate or below, forcing the multiple back toward 18.5x. That combination would take the stock to the analyst low target of $257.00, about 23% below the current $334.28, and a break below the 52-week low of $282.00 (15.6% downside) would confirm the downtrend and target new lows. In a severe de-rating with estimate cuts, an investor could realistically lose 23%-30% from current levels, and the -35.44% historical max drawdown shows such a move is within the stock's demonstrated range rather than a tail scenario.
FAQ
The most severe risk is estimate risk: analysts model $26.24 forward EPS, roughly 47% above the trailing run-rate, and a cut toward the $25.29 low estimate would simultaneously compress the multiple and the earnings base, with the PEG of 4.60 already signaling market doubt. Second is company-specific leadership risk — the surprise CEO transition drove shares to the $282.00 52-week low in late June, and Berkshire's exit under Greg Abel removed a high-profile institutional anchor, leaving a strategic review that could reset 2027 guidance. Third is operational concentration: 60% of revenue comes from the supply-chain segment levered to US store volumes, so continued US traffic declines transmit directly to the top line with limited royalty insulation, and the 12.2% net margin leaves little buffer for commodity or labor cost shocks. Fourth is financial structure: negative book equity (ROE -15.42%, debt-to-equity -1.34) and $46.2 million of quarterly interest expense mean refinancing at higher rates would bite, while the -35.44% max drawdown versus SPY's far milder decline confirms idiosyncratic rather than market risk despite a 0.967 beta.
The 12-month outlook splits into three scenarios. The base case (50% probability, $340–$370) assumes the $26.24 EPS is broadly delivered on low-single-digit revenue growth, margins hold in the 40% gross / 19%–20% operating band, and the stock grinds toward the $356.48 average target as the CEO transition settles. The bull case (25%, $400–$425) requires US same-store sales to turn positive, a credible new-CEO strategic plan with 2027 guidance above consensus, and multiple re-expansion toward 25x forward earnings, landing near the $425 high target. The bear case (25%, $257–$282) assumes negative US same-store sales, a lowered 2027 outlook, and a de-rating toward the 18.5x historical floor, taking the stock to the $257 analyst low. The base case is most likely because the Q3 beat arrested negative sentiment without resolving the traffic question, and the key assumption is that the forward EPS estimate holds.
DPZ screens as modestly undervalued relative to its own history but only fairly valued versus near-term earnings reality. The trailing PE of 23.81x sits in the lower third of the 18.5x–39.4x band it has traded in over recent years, well below the 28.4x–32.7x levels of 2025 and the 39.4x peak in early 2022, while the forward PE of 16.20x represents a 32% compression that is far steeper than the sector's typical forward discount. The PS ratio of 2.90x and EV/EBITDA of 18.04x are undemanding for a franchised platform with 40% gross and 19.3% operating margins. However, the PEG of 4.60 shows the market is discounting the forward estimate, so the apparent cheapness depends entirely on whether $26.24 in EPS is delivered. The market is pricing in execution risk and skepticism about the recovery, not inferior business quality — if estimates hold, the stock is cheap; if they are cut, the discount is deserved.
The risk/reward is balanced but not compelling at $334.28. On the positive side, the stock trades at 16.20x forward earnings versus a 23.81x trailing multiple, sits in the bottom third of its 18.5x–39.4x historical band, generates $635.7 million of trailing free cash flow, and has rebounded 10.29% in the past month against SPY's -4.99% decline. On the negative side, the average analyst target of $356.48 implies only 6.6% upside, 15 of 27 analysts rate Hold, and the bear case target of $257 represents roughly 23% downside if the $26.24 forward EPS is cut. The biggest single risk is that the ~47% earnings recovery embedded in the forward estimate fails to materialize under a new CEO. It is a reasonable buy for valuation-disciplined investors with a 12–24 month horizon who can tolerate event risk, particularly on a pullback toward the $282–300 support zone; it is not a good buy for those seeking near-term upside or income.
DPZ is better suited to a medium-to-long-term holding than to short-term trading. The business is a mature, 99%-franchised compounder with modest 3.36% revenue growth, so returns depend on the earnings recovery and multiple normalization playing out over several quarters rather than on near-term catalysts. Volatility is moderate on a beta basis (0.967) but the -35.44% max drawdown and the 65% spread between the $257 and $425 analyst targets show event risk around earnings and the CEO transition is high, which argues against leveraged short-term positioning. The 1.65% dividend yield with a conservative 39.4% payout ratio and consistent buybacks (diluted shares down from 34.1 million to 33.1 million year-over-year) reward patience. A minimum holding period of 12–24 months is appropriate to capture at least two to three earnings cycles and give US same-store sales time to inflect; short-term traders should instead focus on the defined $282 support and $367 resistance levels.